Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Elife ; 92020 07 30.
Article in English | MEDLINE | ID: covidwho-690669

ABSTRACT

The COVID-19 pandemic caused by the SARS-CoV-2 has recently emerged as a serious jolt to human life and economy. Initial knowledge established pulmonary complications as the chief symptom, however, the neurological aspect of the disease is also becoming increasingly evident. Emerging reports of encephalopathies and similar ailments with the detection of the virus in the CSF has elicited an urgent need for investigating the possibility of neuroinvasiveness of the virus, which cannot be ruled out given the expression of low levels of ACE2 receptors in the brain. Sensory impairments of the olfactory and gustatory systems have also been reported in a large proportion of the cases, indicating the involvement of the peripheral nervous system. Hence, the possibility of neurological damage caused by the virus demands immediate attention and investigation of the mechanisms involved, so as to customize the treatment of patients presenting with neurological complications.


Subject(s)
Betacoronavirus , Coronavirus Infections/complications , Nervous System Diseases/etiology , Pneumonia, Viral/complications , Ageusia/etiology , Angiotensin-Converting Enzyme 2 , Betacoronavirus/pathogenicity , Betacoronavirus/physiology , Brain/metabolism , Brain/virology , COVID-19 , Cerebrovascular Disorders/etiology , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Encephalitis, Viral/etiology , Host Microbial Interactions , Humans , Models, Neurological , Nervous System Diseases/physiopathology , Nervous System Diseases/virology , Olfaction Disorders/etiology , Pandemics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , Receptors, Virus/metabolism , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL